Working… Menu

Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer (Consortium-IO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04208958
Recruitment Status : Active, not recruiting
First Posted : December 23, 2019
Last Update Posted : June 23, 2021
Bristol-Myers Squibb
Information provided by (Responsible Party):
Vedanta Biosciences, Inc.

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : July 2021
Estimated Study Completion Date : August 2022